Literature DB >> 508675

Effect of lisuride on inhibition of lactation and serum prolactin.

L De Cecco, P L Venturini, N Ragni, P Rossato, C Maganza, G Gaggero, R Horowski.   

Abstract

Lisuride, a new semisynthetic ergot derivative, was given to 53 women to inhibit lactation; 26 women had 300 micrograms daily and 27 had 600 micrograms daily for seven days. Eight lactating women acted as controls. Lisuride effectively inhibited lactation and also suppressed the serum prolactin levels; the latter effect was dose related. Lisuride produced no untoward side effects.

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 508675     DOI： 10.1111/j.1471-0528.1979.tb10722.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN： 0306-5456


  4 in total

Review 1.  Treatments for suppression of lactation.

Authors:  Olufemi T Oladapo; Bukola Fawole
Journal:  Cochrane Database Syst Rev       Date:  2012-09-12

Review 2.  Drug-induced changes in prolactin secretion. Clinical implications.

Authors:  K Hell; H Wernze
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Nov-Dec

3.  Somatotropin secretion in hyperprolactinemia.

Authors:  B V Gorgoshidze; M A Sabakhtarashvili; E G Veinberg; R B Kurashvili; M G Dundua
Journal:  Neurosci Behav Physiol       Date:  1983 Mar-Apr

4.  Effect of terguride on prolactin levels in normal, puerperal and hyperprolactinaemic women.

Authors:  P L Venturini; R Horowski; M Valenzano; S Costantini; V Fasce; F Gorlero; E Rainer; L De Cecco
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.